News from northwest biotherapeutics, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 11, 2014, 11:59 ET
Northwest Biotherapeutics Logo

NW BIO RECAPS 2014 PROGRESS, PROVIDES DCVAX-DIRECT TRIAL UPDATE AT OPPENHEIMER'S 25TH ANNUAL HEALTHCARE CONFERENCE

 Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies for...

Nov 19, 2014, 15:20 ET
Northwest Biotherapeutics Logo.

NW BIO ANNOUNCES FINANCINGS TOTALING $35 MILLION TO EXPAND AND ACCELERATE DCVAX®-L AND DCVAX®-DIRECT PROGRAMS

Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies for solid...

Nov 07, 2014, 09:15 ET
Northwest Biotherapeutics Logo.

NW BIO MAKING A JOINT POSTER PRESENTATION ON ITS DCVAX-DIRECT TRIAL AT THE 29TH ANNUAL SITC MEETING

Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies for solid...

Oct 14, 2014, 09:01 ET
Northwest Biotherapeutics Logo

DCVAX®-L HOSPITAL EXEMPTION PROGRAM NOW UNDER WAY IN GERMANY

 Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid...

Oct 07, 2014, 09:00 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

NW BIO ANNOUNCES $11.5 MILLION FINANCING

 Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid...

Sep 16, 2014, 08:00 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM)

Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor...

Sep 15, 2014, 08:00 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

NW BIO CEO TO PRESENT AT SMi's 3rd ANNUAL CANCER VACCINES CONFERENCE IN LONDON

Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies for solid...

Sep 08, 2014, 08:15 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

NW BIO TO PRESENT UPDATES AT RODMAN RENSHAW 16TH ANNUAL GLOBAL INVESTMENT CONFERENCE

 Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid...

Aug 19, 2014, 14:44 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

NW BIO COMPLETES THE CLOSING OF ITS $17.5 MILLION CONVERTIBLE NOTE OFFERING

 Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid...

Aug 14, 2014, 11:47 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

NW BIO ANNOUNCES PRICING OF $17.5 MILLION OFFERING OF CONVERTIBLE NOTES

Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio") today announced the pricing of $17.5 million aggregate principal amount of its unsecured...

Aug 13, 2014, 09:26 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

NW BIO CORRECTS ONGOING FALSE CLAIMS BY FEUERSTEIN ABOUT PHASE III TRIAL OF DCVAX®-L, AND INTERIM ANALYSIS

 Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid...

Aug 11, 2014, 08:15 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

NW BIO PROVIDES UPDATE ABOUT PHASE III DCVAX®-L TRIAL FOR GBM AND "INFORMATION ARM" COMPASSIONATE USE PATIENTS

 Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid...

Aug 11, 2014, 08:15 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

NW BIO OBTAINS APPROVALS FOR ENHANCEMENTS OF PHASE III TRIAL OF DCVAX®-L FOR GBM BRAIN CANCER

Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor...

Jul 16, 2014, 08:15 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

NW BIO ANNOUNCES COMPLETION OF DCVAX®-DIRECT PHASE I TRIAL RECRUITMENT

 Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid...

Jun 20, 2014, 08:25 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

NW BIO REAFFIRMS DCVAX®-DIRECT CLINICAL TRIAL INTERIM DATA ANNOUNCEMENTS

 Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid...

Jun 16, 2014, 08:15 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

NW BIO NAMED TO TWO RUSSELL INDEXES

 Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid...

Jun 11, 2014, 08:15 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

DCVAX-DIRECT TRIAL UPDATE INDICATES FURTHER POSITIVE RESPONSES; 3 CASE STUDIES SHOW NO LIVE TUMOR CELLS IN INJECTED TUMORS

 Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune...

Jun 10, 2014, 08:15 ET

DCVAX®-L PHASE III TRIAL INITIATED IN GERMANY

Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor...

Jun 04, 2014, 11:23 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

NW BIO TO PRESENT AT JEFFERIES 2014 GLOBAL HEALTHCARE CONFERENCE

 Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies...

May 29, 2014, 09:27 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

NW BIO REFUTES MORE FALSE CLAIMS BY FEUERSTEIN

Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid...